However, Neat1 and H19 remarkably showed the highest fold change at the symptomatic stages, raising them as good candidates for further study in humans as biomarkers to support and/or confirm ALS diagnosis. The gene discussed is NEAT1; the disease is amyotrophic lateral sclerosis.